These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8940041)

  • 1. Binding affinity of transforming growth factor-beta for its type II receptor is determined by the C-terminal region of the molecule.
    Qian SW; Burmester JK; Tsang ML; Weatherbee JA; Hinck AP; Ohlsen DJ; Sporn MB; Roberts AB
    J Biol Chem; 1996 Nov; 271(48):30656-62. PubMed ID: 8940041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ternary complex of transforming growth factor-beta1 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily.
    Radaev S; Zou Z; Huang T; Lafer EM; Hinck AP; Sun PD
    J Biol Chem; 2010 May; 285(19):14806-14. PubMed ID: 20207738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2.
    del Re E; Babitt JL; Pirani A; Schneyer AL; Lin HY
    J Biol Chem; 2004 May; 279(21):22765-72. PubMed ID: 14996829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta (TGF-beta) binding to the extracellular domain of the type II TGF-beta receptor: receptor capture on a biosensor surface using a new coiled-coil capture system demonstrates that avidity contributes significantly to high affinity binding.
    De Crescenzo G; Pham PL; Durocher Y; O'Connor-McCourt MD
    J Mol Biol; 2003 May; 328(5):1173-83. PubMed ID: 12729750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TbetaR-II discriminates the high- and low-affinity TGF-beta isoforms via two hydrogen-bonded ion pairs.
    Baardsnes J; Hinck CS; Hinck AP; O'Connor-McCourt MD
    Biochemistry; 2009 Mar; 48(10):2146-55. PubMed ID: 19161338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor.
    Rotzer D; Roth M; Lutz M; Lindemann D; Sebald W; Knaus P
    EMBO J; 2001 Feb; 20(3):480-90. PubMed ID: 11157754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II.
    Guerrero-Esteo M; Sanchez-Elsner T; Letamendia A; Bernabeu C
    J Biol Chem; 2002 Aug; 277(32):29197-209. PubMed ID: 12015308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pivotal role for the transmembrane domain in transforming growth factor-beta receptor activation.
    Zhu HJ; Sizeland AM
    J Biol Chem; 1999 Apr; 274(17):11773-81. PubMed ID: 10206994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
    Deng X; Bellis S; Yan Z; Friedman E
    Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different domains regulate homomeric and heteromeric complex formation among type I and type II transforming growth factor-beta receptors.
    Rechtman MM; Nakaryakov A; Shapira KE; Ehrlich M; Henis YI
    J Biol Chem; 2009 Mar; 284(12):7843-52. PubMed ID: 19147499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist.
    Demetriou M; Binkert C; Sukhu B; Tenenbaum HC; Dennis JW
    J Biol Chem; 1996 May; 271(22):12755-61. PubMed ID: 8662721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer.
    Takahashi K; Akatsu Y; Podyma-Inoue KA; Matsumoto T; Takahashi H; Yoshimatsu Y; Koinuma D; Shirouzu M; Miyazono K; Watabe T
    J Biol Chem; 2020 Sep; 295(36):12559-12572. PubMed ID: 32631954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An engineered transforming growth factor β (TGF-β) monomer that functions as a dominant negative to block TGF-β signaling.
    Kim SK; Barron L; Hinck CS; Petrunak EM; Cano KE; Thangirala A; Iskra B; Brothers M; Vonberg M; Leal B; Richter B; Kodali R; Taylor AB; Du S; Barnes CO; Sulea T; Calero G; Hart PJ; Hart MJ; Demeler B; Hinck AP
    J Biol Chem; 2017 Apr; 292(17):7173-7188. PubMed ID: 28228478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acids 67 and 68 of transforming growth factor-beta regulate binding to a glycosyl phosphatidyl inositol-linked membrane protein on vascular endothelial cells.
    Zhang KQ; Polga D; Salzman SA; Burmester JK
    Cytokines Cell Mol Ther; 2002 Mar; 7(1):25-30. PubMed ID: 12171248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
    Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
    J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta1 receptor II is downregulated by E1A in adenovirus-infected cells.
    Tarakanova VL; Wold WS
    J Virol; 2003 Sep; 77(17):9324-36. PubMed ID: 12915548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β sensitivity is determined by N-linked glycosylation of the type II TGF-β receptor.
    Kim YW; Park J; Lee HJ; Lee SY; Kim SJ
    Biochem J; 2012 Aug; 445(3):403-11. PubMed ID: 22571197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational modeling of TGF-β2:TβRI:TβRII receptor complex assembly as mediated by the TGF-β coreceptor betaglycan.
    Madamanchi A; Ingle M; Hinck AP; Umulis DM
    Biophys J; 2023 Apr; 122(7):1342-1354. PubMed ID: 36869592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma.
    Knaus PI; Lindemann D; DeCoteau JF; Perlman R; Yankelev H; Hille M; Kadin ME; Lodish HF
    Mol Cell Biol; 1996 Jul; 16(7):3480-9. PubMed ID: 8668164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth factor-binding sequence in human alpha2-macroglobulin targets the receptor-binding site in transforming growth factor-beta.
    Arandjelovic S; Freed TA; Gonias SL
    Biochemistry; 2003 May; 42(20):6121-7. PubMed ID: 12755614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.